RecruitingACTRN12605000645651

HPV infection and cervial dysplasia in bone marrow transplant recipients

A study to evaluate the impact of immunosuppression associated with bone marrow transplantation on HPV infection and cervial dysplasia, the impact of conditioning regimens on cytology and the difference in outcome parameters between allogeneic and autologous transplant recipients.


Sponsor

Melbourne Health

Enrollment

82 participants

Start Date

Oct 21, 1998

Study Type

Observational

Conditions


Eligibility

Sex: Both males and females

Plain Language Summary

Simplified for easier understanding

This study is following women who are about to undergo a bone marrow transplant to check whether they are more likely to develop HPV (human papillomavirus) infection or cervical cell changes after the transplant. Bone marrow transplants can weaken the immune system, and researchers want to understand how this affects the risk of HPV-related problems over the following three years. You may be eligible if: - You are about to undergo a bone marrow transplant (either from a donor or using your own stem cells) - Your doctors expect you to survive for the full 3-year follow-up period of the study You may NOT be eligible if: - There are no specific exclusion criteria listed for this study Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

None

None


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000645651


Related Trials